Latest News

Researchers at MUSC Hollings Cancer Center are working to develop new drug combinations for people with treatment-resistant cancer.

A new modeling study provides insight for guideline-writing bodies on who should be screened for anal cancer, how often and with which method.

Jalayia McDowell wasn't sure about spending her summers studying cancer. But now the new high school graduate is headed to college to study biology.

Two Hollings cancer researchers are the sole South Carolinians selected for a life sciences entrepreneurship accelerator.

Spc. Christian Sutton has been on a mission to get soldiers to sign up for the bone marrow registry. He recently got to make a donation himself.

With $26.5 million in new funding, SCTR will clear the way for the translation of research breakthroughs into clinics and communities.

A Hollings researcher is working on an idea to help oral oncologists better predict which patients are likely to develop cancer.

What doctors can do for aggressive form of prostate cancer Joe Biden is facing, and the impact the former president’s condition may have on others.

Two Hollings Cancer Center researchers are studying new ways to bring depression treatment to cancer survivors.

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.